Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The selective estrogen receptor modulator DT56a (Femarelle) does not affect platelet reactivity in normal or thrombophilic postmenopausal women.
Nachtigall MJ, Jessel RH, Flaumenhaft R, Nachtigall R, Yoles I, Naftolin F, Nachtigall LE. Nachtigall MJ, et al. Among authors: yoles i. Menopause. 2011 Mar;18(3):285-8. doi: 10.1097/gme.0b013e3181f2f01a. Menopause. 2011. PMID: 21037489
DT56a (Femarelle): a natural selective estrogen receptor modulator (SERM).
Somjen D, Katzburg S, Knoll E, Hendel D, Stern N, Kaye AM, Yoles I. Somjen D, et al. J Steroid Biochem Mol Biol. 2007 May;104(3-5):252-8. doi: 10.1016/j.jsbmb.2007.03.004. Epub 2007 Mar 14. J Steroid Biochem Mol Biol. 2007. PMID: 17428655
DT56a stimulates gender-specific human cultured bone cells in vitro.
Somjen D, Katzburg S, Lieberherr M, Hendel D, Yoles I. Somjen D, et al. J Steroid Biochem Mol Biol. 2006 Jan;98(1):90-6. doi: 10.1016/j.jsbmb.2005.08.002. Epub 2005 Oct 21. J Steroid Biochem Mol Biol. 2006. PMID: 16243521
The aim of the present study was to analyze the effects of DT56a in vitro on human-derived bone cultured osteoblasts (Ob), by measuring its effects, at different concentrations, on DNA synthesis, CK and alkaline phosphatase (ALP) specific activities as well as changes in intracel …
The aim of the present study was to analyze the effects of DT56a in vitro on human-derived bone cultured osteoblasts (Ob), by measuring its …
DT56a (Femarelle) stimulates bone formation in female rats.
Somjen D, Katzburg S, Livne E, Yoles I. Somjen D, et al. BJOG. 2005 Jul;112(7):981-5. doi: 10.1111/j.1471-0528.2005.00573.x. BJOG. 2005. PMID: 15958004
Tofupill/Femarelle (DT56a): a new phyto-selective estrogen receptor modulator-like substance for the treatment of postmenopausal bone loss.
Yoles I, Yogev Y, Frenkel Y, Nahum R, Hirsch M, Kaplan B. Yoles I, et al. Menopause. 2003 Nov-Dec;10(6):522-5. doi: 10.1097/01.GME.0000064864.58809.77. Menopause. 2003. PMID: 14627860 Clinical Trial.
DT56a stimulates creatine kinase specific activity in vascular tissues of rats.
Somjen D, Yoles I. Somjen D, et al. J Endocrinol Invest. 2003 Oct;26(10):966-71. doi: 10.1007/BF03348193. J Endocrinol Invest. 2003. PMID: 14759068
In the present study we measured the effects of DT56a on vascular tissues i.e. aorta (Ao) and the left ventricle of the heart (Lv). ...
In the present study we measured the effects of DT56a on vascular tissues i.e. aorta (Ao) and the left ventricle of the heart (Lv). . …
The effects of native and synthetic estrogenic compounds as well as vitamin D less-calcemic analogs on adipocytes content in rat bone marrow.
Somjen D, Katzburg S, Kohen F, Gayer B, Posner GH, Yoles I, Livne E. Somjen D, et al. Among authors: yoles i. J Endocrinol Invest. 2011 Feb;34(2):106-10. doi: 10.1007/BF03347039. Epub 2010 Jun 11. J Endocrinol Invest. 2011. PMID: 20543554
DT56a (Femarelle), contrary to estradiol-17β, is effective in human derived female osteoblasts in hyperglycemic condition.
Somjen D, Katzburg S, Sharon O, Hendel D, Yoles I. Somjen D, et al. Among authors: yoles i. J Steroid Biochem Mol Biol. 2011 Jan;123(1-2):25-9. doi: 10.1016/j.jsbmb.2010.10.001. Epub 2010 Oct 14. J Steroid Biochem Mol Biol. 2011. PMID: 20951203
20 results
Jump to page
Feedback